2008Huaxi yaoxue zazhiRequires access

Relative bioavailability of Azithromycin capsules in healthy volunteers

Junyi Yang

Open publisher page 0 citations

Abstract

OBJECTIVE To investigate the pharmacokinetics and bioequivalence of Azithromycin capsules in healthy volunteers.METHODS A randomized crossover design was performed in 24 healthy male volunteers.In the two study periods,a single 1g dose of either test or reference preparation was administered to each volunteer.Azithromycin concentration in plasma was detected by HPLC.The experiment data were calculated with DAS program.The results were analyzed by ANOVA and two one-way test.RESULTS The relative bioavailability of azithromycin in the test was 104.06%±11.15%;AUC0-t of azithromycin of test and reference preparations were 23.98±7.42,23.35±7.70 μg·h·ml-1;Tmax were 2.63±0.42,2.46±0.25 h;Cmax were 1.08±0.22,1.13±0.23 μg·ml-1.CONCLUSION Bioequivalent evaluation of two preparations by analyzing with two one-way test and rank sum test shows that the two preparations are bioequivalent.

About this research paper

What this paper is about

OBJECTIVE To investigate the pharmacokinetics and bioequivalence of Azithromycin capsules in healthy volunteers.METHODS A randomized crossover design was performed in 24 healthy male volunteers.In the two study periods,a single 1g dose of either test or reference preparation was administered to each volunteer.Azithromycin concentration in plasma was detected by HPLC.The experiment data were calculated with DAS program.The results were analyzed by ANOVA and two one-way test.RESULTS The relative bioavailability of azithromycin in the test was 104.06%±11.15%;AUC0-t of azithromycin of test and reference preparations were 23.98±7.42,23.35±7.70 μg·h·ml-1;Tmax were 2.63±0.42,2.46±0.25 h;Cmax were 1.08±0.22,1.13±0.23 μg·ml-1.CONCLUSION Bioequivalent evaluation of two preparations by analyzing with two one-way test and rank sum test shows that the two preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To investigate the pharmacokinetics and bioequivalence of Azithromycin capsules in healthy volunteers.METHODS A randomized crossover design was performed in 24 healthy male volunteers.In the two study periods,a single 1g dose of either test or reference preparation was administered to each volunteer.Azithromycin concentration in plasma was detected by HPLC.The experiment data were calculated with DAS program.The results were analyzed by ANOVA and two one-way test.RESULTS The relative bioavailability of azithromycin in the test was 104.06%±11.15%;AUC0-t of azithromycin of test and reference preparations were 23.98±7.42,23.35±7.70 μg·h·ml-1;Tmax were 2.63±0.42,2.46±0.25 h;Cmax were 1.08±0.22,1.13±0.23 μg·ml-1.CONCLUSION Bioequivalent evaluation of two preparations by analyzing with two one-way test and rank sum test shows that the two preparations are bioequivalent.

Key concepts: Bioequivalence, Azithromycin, Bioavailability, Volunteer, Chemistry, Cmax, Pharmacokinetics, Crossover study

Related papers

Back to paper searchBrowse research topicsOriginal source
Relative bioavailability of Azithromycin capsules in healthy volunteers — Research Paper | ScholarLens